Skip to main content

Table 2 Anthropometric measures at baseline (ITT: number (N) = 64) in groups to be treated with polyglucosamine and orlistat

From: Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Variable

Total

Group polyglucosamine

Group orlistat

pa/b

N

64

32

32

Gender (male/female)

28/36

16/16

12/20

P = 0.313a

Age (years)

50.0 ± 9.17

50.0 ± 9.10

50.1 ± 9.38

P = 0.989b

Weight (kg)

99.4 ± 12.33

100.6 ± 13.22

98.2 ± 11.47

P = 0.446b

Height (m)

169.3 ± 8.09

170.3 ± 7.60

168.4 ± 8.58

P = 0.358b

BMI (kg/m2)

34.7 ± 4.21

34.6 ± 3.70

34.8 ± 4.73

P = 0.896b

WC (cm)

111.2 ± 10.66

112.4 ± 10.95

110.0 ± 10.38

P = 0.358b

  1. aChi square test; bt test